UNSPSC 51382003: Flunoxaprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H12FNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UKU5U19W9M, chemically known as 5-benzoxazoleacetic acid, 2-(4-fluorophenyl)-alpha-methyl-, (s)- but generally known as flunoxaprofen, which bears US NIH Compound Identifier 68869. European Medicines Agency schedules Flunoxaprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07713MIG.

UNSPSC 51382003 Flunoxaprofen is a Commodity code that represents a specific pharmaceutical product, but the recent state and local procurement activity tagged under it does not involve flunoxaprofen purchase — instead, Seminole County, Florida posted an IFB for naloxone (opioid antagonist) and safe drug deactivation systems. The mismatch suggests that the code assignment in this instance may reflect a data-entry or classification error rather than genuine procurement demand for flunoxaprofen itself. State and local agencies do procure pharmaceuticals, medical supplies, and harm-reduction equipment through similar competitive processes, but the tagged opportunity here does not align with the code's nominal scope.

Seminole County's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement required electronic bidding through the county's e-Procurement Portal, included E-Verify and drug-free workplace compliance, and carried an initial two-year contract term with an option for one-year renewal. No explicit set-aside or disadvantaged-enterprise designations were noted. Without additional opportunities in the source data tagged correctly to the flunoxaprofen code, this summary cannot characterize the geographic spread or issuing-body mix for genuine flunoxaprofen procurement at the state and local level.